190 related articles for article (PubMed ID: 27976958)
1. [Not Available].
Plate A; Vallelian F; Herfs G
Praxis (Bern 1994); 2016; 105(25):1503-1506. PubMed ID: 27976958
[No Abstract] [Full Text] [Related]
2. [CME: Adult Still disease].
Etter M; Vallelian F; Herfs G
Praxis (Bern 1994); 2015 Oct; 104(21):1117-25. PubMed ID: 26463902
[No Abstract] [Full Text] [Related]
3. A comprehensive review on adult onset Still's disease.
Giacomelli R; Ruscitti P; Shoenfeld Y
J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of macrophage activation syndrome complicating adult Still disease with anakinra.
Loh NK; Lucas M; Fernandez S; Prentice D
Intern Med J; 2012 Dec; 42(12):1358-62. PubMed ID: 23253002
[TBL] [Abstract][Full Text] [Related]
5. Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome.
Kobayashi M; Takahashi Y; Yamashita H; Kaneko H; Mimori A
Mod Rheumatol; 2011 Feb; 21(1):92-6. PubMed ID: 20737186
[TBL] [Abstract][Full Text] [Related]
6. Macrophage Activation Syndrome Associated With Adult Onset Still's Disease.
Gulzar M; Sabir A; Hamdani MA; Saadia A
J Ayub Med Coll Abbottabad; 2018; 30(2):289-292. PubMed ID: 29938438
[TBL] [Abstract][Full Text] [Related]
7. Successful use of short-term add-on tocilizumab for refractory adult-onset still's disease with macrophage activation syndrome despite treatment with high-dose glucocorticoids, cyclosporine, and etoposide.
Ohmura SI; Uehara K; Yamabe T; Tamechika S; Maeda S; Naniwa T
Mod Rheumatol Case Rep; 2020 Jul; 4(2):202-207. PubMed ID: 33086994
[TBL] [Abstract][Full Text] [Related]
8. Blockade of interleukin 1 receptor in Still's disease affects activation of peripheral T-lymphocytes.
Youssef J; Lazaro E; Blanco P; Viallard JF
J Rheumatol; 2008 Dec; 35(12):2453-6. PubMed ID: 19143047
[No Abstract] [Full Text] [Related]
9. Adult-onset Still's disease with macrophage activation syndrome successfully treated with a combination of methotrexate and etanercept.
Maeshima K; Ishii K; Iwakura M; Akamine M; Hamasaki H; Abe I; Haranaka M; Tatsukawa H; Yoshimatsu H
Mod Rheumatol; 2012 Feb; 22(1):137-41. PubMed ID: 21670967
[TBL] [Abstract][Full Text] [Related]
10. Adult-onset Still's disease with macrophage activation syndrome diagnosed and treated based on cytokine profiling: a case-based review.
Goda K; Kenzaka T; Hoshijima M; Yachie A; Akita H
Rheumatol Int; 2020 Jan; 40(1):145-152. PubMed ID: 31541282
[TBL] [Abstract][Full Text] [Related]
11. Case report: Methotrexate's role as a potential inducer of macrophage activation syndrome in Still's disease.
Aldrea F; Klib M; Jalal S; Najak A; Aji W
Int J Rheum Dis; 2024 May; 27(5):e15183. PubMed ID: 38733089
[No Abstract] [Full Text] [Related]
12. Visceral leishmaniasis triggering (mimicking) macrophage activation syndrome in a patient with adult onset Still disease.
Barešić M; Janka GE; Gjadrov-Kuveždić K; Zekan Š; Anić B
Intern Med J; 2016 Nov; 46(11):1347-1348. PubMed ID: 27813355
[No Abstract] [Full Text] [Related]
13. Fulminant myocarditis and macrophage activation syndrome secondary to adult-onset Still's disease successfully treated with tocilizumab.
Savage E; Wazir T; Drake M; Cuthbert R; Wright G
Rheumatology (Oxford); 2014 Jul; 53(7):1352-3. PubMed ID: 24609056
[No Abstract] [Full Text] [Related]
14. Rescued from desperation: adult-onset Still's disease with life-threatening interstitial lung disease and macrophage activation : Successful treatment by Tocilizumab.
Zhang G; Liu W; Zhang X; Liu L
Z Rheumatol; 2022 May; 81(4):335-338. PubMed ID: 34378080
[TBL] [Abstract][Full Text] [Related]
15. [Adult onset Still's disease with small vessel vasculitis].
Hoff P; Hoyer BF; Schneider U; Kneitz C; Burmester GR; Buttgereit F
Z Rheumatol; 2015 Aug; 74(6):540-2. PubMed ID: 26231832
[TBL] [Abstract][Full Text] [Related]
16. A Recurrent Case of Adult-onset Still's Disease with Concurrent Acalculous Cholecystitis and Macrophage Activation Syndrome/Hemophagocytic Lymphohistiocytosis Successfully Treated with Combination Immunosuppressive Therapy.
Arai Y; Ishikawa Y; Abe K; Kato Y; Abe D; Fujiwara M; Kita Y
Intern Med; 2021 Jun; 60(12):1955-1961. PubMed ID: 33518559
[TBL] [Abstract][Full Text] [Related]
17. [Adult Still's disease: study of a series of 11 cases].
Ben Taarit C; Turki S; Ben Maïz H
J Mal Vasc; 2002 Feb; 27(1):31-5. PubMed ID: 12070839
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment with tacrolimus of refractory adult-onset Still's disease.
Ohe M; Oku K; Kono M; Bohgaki T
Korean J Intern Med; 2014 Mar; 29(2):259-61. PubMed ID: 24648814
[No Abstract] [Full Text] [Related]
19. [Adult-onset Still's disease: case report in Dakar, Senegal].
Gning SB; Diallo I; Fall CA; Ndiaye B; Ba Fall K; Fall F; Fall PD; Mbaye PS
Med Trop (Mars); 2011 Dec; 71(6):588-90. PubMed ID: 22393626
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism as initial manifestation of adult onset Still's disease.
Merashli M; Jawad A; Ames PR
Scand J Rheumatol; 2015; 44(4):340-1. PubMed ID: 25992807
[No Abstract] [Full Text] [Related]
[Next] [New Search]
